G-Protein Coupled Receptors Global Market Report 2024 - By Size, Share, Demand, Growth, Forecast To 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

G-Protein Coupled Receptors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $4.09 billion In 2028 At A CAGR Of 6.5%.
The g-protein coupled receptors market size has grown strongly in recent years. It will grow from $2.97 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to drug discovery advances, fda approvals, genomic discoveries, emerging markets, market consolidation, growing aging population.

The g-protein coupled receptors market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine, increased focus on rare diseases, artificial intelligence in drug discovery, patient-centric drug development, environmental and social factors, biosimilar market growth. Major trends in the forecast period include biotechnology advancements, increased r&d investment, technological innovations, collaborations and partnerships, digital therapeutics.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

G-Protein Coupled Receptors Market Major Segments
The g-protein coupled receptors market covered in this report is segmented -
1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding and GTPγS Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Key Driver - G-Protein-Coupled Receptors Market Poised For Growth Driven By Escalating Cancer Prevalence
The rising prevalence of cancer is expected to propel the growth of the G-protein-coupled receptors market going forward. Cancer is an illness in which abnormal cells can infect surrounding tissues and spread uncontrollably. The lymphatic and vascular systems of the body are further routes by which cancer cells might spread. GPCRs control the processes identified as the defining characteristics of cancer, including proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For instance, in March 2023, according to the American Society of Clinical Oncology (ASCO), a US-based non-profit organization working for cancer care, in the United States, kidney cancer will be discovered in 81,800 individuals in 2023 (52,360 males and 29,440 women. Furthermore, in April 2022, Breast cancer surpassed lung cancer to become the most commonly diagnosed cancer worldwide, affecting an estimated 2.3 million women in 2021 alone, according to the Breast Cancer Research Foundation, a US-based not-for-profit organization in breast cancer for clinical and translational research. In the United States, where breast cancer has been the most frequent cancer for many years, 281,550 women are expected to be diagnosed in 2021 Therefore, the rising prevalence of cancer is driving the growth of the G-protein coupled receptors market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=11976&type=smp

Prominent Trend - Lifearc Ventures Backs Maxion Therapeutics And Septerna Inc. To Propel G-Protein-Coupled Receptor Research
Investment to advance GPCR screening and antibody development is a key trend gaining popularity in the G-protein-coupled receptor (GPCR) market. Major companies operating in GPCR are focusing on attaining investment for developing drugs and medication technologies related to GPCR-driven diseases. For instance, in February 2023, LifeArc Ventures, a UK-based venture capital firm, invested $16 million in Maxion Therapeutics, a UK-based drug discovery company, to advance antibody development for previously untreatable ion channel and GPCR-driven disorders. This funding will enable the development of antibody therapeutics targeting ion channels and G-protein-coupled receptors (GPCRs) using the proprietary KnotBody technology. The KnotBody platform enables the discovery of biologicals against ion channels and GPCRs, using naturally occurring cysteine-rich mini proteins. Moreover, Septerna Inc., a US-based biotechnology company, announced its launch and Series A financing of $100 million. This Series A funding will be used for developing its emerging pipeline of innovative GPCR-targeted medication programs powered by the Native Complex Platform and covering numerous therapeutic areas.

G-Protein Coupled Receptors Market Players
Major companies operating in the g-protein coupled receptors market report are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the G-protein coupled receptors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. G-Protein Coupled Receptors Market Report Structure
3. G-Protein Coupled Receptors Market Trends And Strategies
4. G-Protein Coupled Receptors Market - Macro Economic Scenario
5. G-Protein Coupled Receptors Market Size And Growth
…..
27. G-Protein Coupled Receptors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.